Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Aug 2026 for LIGAND PHARMACEUTICALS INCORPORATED, €1.8M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jason Haas: trading record in brief
Jason Haas is a declared insider of Ligand Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 12 June 2026 to 12 August 2026, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 12 August 2026 with a transaction (€1.8M) in Ligand Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jason Haas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
7,138 shares@ US$292.8078CommonSEC144:0001950047-26-008011
6,461 shares@ US$256.00100.0% of flowCommonSEC144:0001950047-26-005992
2 of 2 declarations
